Physician profile
Richard Slagle
NPI 1306247036
$977.40
in general payments reported to CMS, 2019-2025
19 companies · $977 in 2025
The $977 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651 · Education: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.43 |
| Education | $325.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $159.41 | 2025 | Talvey, Darzalex, Tecvayli |
| Incyte Corporation | $138.45 | 2025 | Monjuvi, Zynyz |
| Aveo Pharmaceuticals, INC. | $96.61 | 2025 | |
| Seagen INC. | $80.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $76.26 | 2025 | |
| Madrigal Pharmaceuticals | $47.34 | 2025 | Rezdiffra |
| Bayer Healthcare Pharmaceuticals INC. | $47.30 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $46.25 | 2025 | Calquence |
| Daiichi Sankyo INC. | $37.24 | 2025 | Enhertu |
| Invivyd INC | $34.36 | 2025 | Pemgarda |
| Pfizer INC. | $34.03 | 2025 | |
| Corcept Therapeutics | $33.50 | 2025 | Korlym |
| Emd Serono, INC. | $26.45 | 2025 | |
| Menarini Silicon Biosystems, INC. | $23.38 | 2025 | |
| Cycle Pharmaceuticals INC | $21.79 | 2025 | Phyrago |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $21.30 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.27 | 2025 | Fruzaqla |
| Merck Sharp & Dohme LLC | $17.98 | 2025 | Keytruda, Keytruda Qlex |
| Eisai INC. | $14.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Slagle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.